AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- A single dose of mivocabtagene autoleucel (miv-cel), an autologous CD19 chimeric antigen receptor (CAR)-T cell therapy, showed benefit in people with stiff person syndrome (SPS) in the pivotal phase II KYSA-8 trial. The 26-person...
Source
MedPage Today
Opens original article in a new tab
The constant pressure that the heart is under from beating thousands of times a day may create an environment hostile to cancers
The Trump administration, in a stark departure from the "Just Say No" era, is funding psychedelics research and rescheduling marijuana.
Legislators in two states are resisting efforts to restrict prescription drug affordability boards.
(MedPage Today) -- SAN DIEGO -- Patients with operable non-small cell lung cancer (NSCLC) had significantly longer event-free survival (EFS) with perioperative chemoimmunotherapy, a large randomized trial from China showed. After a median follow...
